The adjusted HR for GLP1-RA after BMS compared to BMS only was 0.31, 95% CI: 0.11-0.93
While Canada was the first to lose patent protection for semaglutide in January, the Canadian health regulator hasnt approved any generics so far, effectively making India the first major market to see a flood of copycat versions
The bill would reinforce fairness in compensation practices across school systems and reflect the value of classroom instruction in district-level decision making, Adams said
In Phase 2 trial data (Rosenstock et al., NEJM 2023), participants with type 2 diabetes showed meaningful improvements in HbA1c within the first eight weeks
Efficacy of noiiglutide injection on body weight in obese Chinese adults without diabetes: A multicentre, randomized, double-blind, placebo-controlled, phase 2 trial